Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children

This study has been completed.
Information provided by:
GlaxoSmithKline Identifier:
First received: February 16, 2006
Last updated: September 29, 2011
Last verified: September 2011